Theravance Biopharma
Posted on: July 13, 2022
By: Kim Berlowitz
With: Comments Off on Theravance Biopharma
MTS served as financial advisor to Theravance Biopharma on its 85% economic interest sale of TRELEGY to Royalty Pharma